List of Excipients in API carbamazepine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing carbamazepine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | TEGRETOL | carbamazepine | 0078-0508 | CITRIC ACID MONOHYDRATE | |
| Novartis Pharmaceuticals Corporation | TEGRETOL | carbamazepine | 0078-0508 | FD&C YELLOW NO. 6 | |
| Novartis Pharmaceuticals Corporation | TEGRETOL | carbamazepine | 0078-0508 | POTASSIUM SORBATE | |
| Novartis Pharmaceuticals Corporation | TEGRETOL | carbamazepine | 0078-0508 | PROPYLENE GLYCOL | |
| Novartis Pharmaceuticals Corporation | TEGRETOL | carbamazepine | 0078-0508 | SORBITOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing carbamazepine
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 | CROSCARMELLOSE SODIUM |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 | ETHYLCELLULOSE |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 | GLYCERIN |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 | LACTOSE MONOHYDRATE |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 | MAGNESIUM STEARATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for carbamazepine
Excipient focus: ACACIA
carbamazepine drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | carbamazepine | 63629-8743 |
| Bryant Ranch Prepack | carbamazepine | 63629-9292 |
| REMEDYREPACK INC | carbamazepine | 70518-3694 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
carbamazepine drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| NCS HealthCare of KY LLC dba Vangard Labs | carbamazepine | 0615-8125 |
| Taro Pharmaceuticals USA Inc | carbamazepine | 51672-4041 |
| Golden State Medical Supply Inc | carbamazepine | 60429-934 |
| Bryant Ranch Prepack | carbamazepine | 63629-8743 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIA
carbamazepine drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | carbamazepine | 0832-6022 |
| Northstar Rx LLC | carbamazepine | 16714-063 |
| Ajanta Pharma USA Inc | carbamazepine | 27241-231 |
| Ascend Laboratories LLC | carbamazepine | 67877-797 |
| Zydus Pharmaceuticals (USA) Inc | carbamazepine | 68382-555 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE A
carbamazepine drug variants containing AMMONIO METHACRYLATE COPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| Taro Pharmaceuticals USA Inc | carbamazepine | 51672-4151 |
| Takeda Pharmaceuticals America Inc | carbamazepine | 54092-171 |
| American Health Packaging | carbamazepine | 60687-311 |
| Prasco Laboratories | carbamazepine | 66993-407 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing AMMONIO METHACRYLATE COPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
carbamazepine drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0029 |
| Morton Grove Pharmaceuticals Inc | carbamazepine | 60432-129 |
| Chartwell RX LLC | carbamazepine | 62135-802 |
| Precision Dose Inc | carbamazepine | 68094-007 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BROWN IRON OXIDE
carbamazepine drug variants containing BROWN IRON OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AustarPharma LLC | carbamazepine | 35561-355 |
| Chartwell RX LLC | carbamazepine er | 62135-927 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing BROWN IRON OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
carbamazepine drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | carbamazepine | 16714-063 |
| Ajanta Pharma USA Inc | carbamazepine | 27241-231 |
| Zydus Pharmaceuticals (USA) Inc | carbamazepine | 68382-555 |
| REMEDYREPACK INC | carbamazepine | 70518-3929 |
| Zydus Lifesciences Limited | carbamazepine | 70771-1468 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE ACETATE
carbamazepine drug variants containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | carbamazepine | 0832-6022 |
| Torrent Pharmaceuticals Limited | carbamazepine | 13668-284 |
| Trigen Laboratories LLC | carbamazepine | 13811-523 |
| Rising Pharma Holdings Inc | carbamazepine | 16571-680 |
| Northstar Rx LLC | carbamazepine | 16714-063 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
carbamazepine drug variants containing CELLULOSE, MICROCRYSTALLINE
carbamazepine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
carbamazepine drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Major Pharmaceuticals | carbamazepine | 0904-7116 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| Atlantic Biologicals Corps | carbamazepine | 17856-4047 |
| Validus Pharmaceuticals LLC | carbamazepine | 30698-419 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| NCS HealthCare of KY LLC dba Vangard Labs | carbamazepine | 0615-3505 |
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
carbamazepine drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | carbamazepine | 16590-475 |
| State of Florida DOH Central Pharmacy | carbamazepine | 53808-0858 |
| Contract Pharmacy Services-PA | carbamazepine | 67046-086 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
carbamazepine drug variants containing CROSCARMELLOSE SODIUM
carbamazepine drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| NCS HealthCare of KY Inc dba Vangard Labs | carbamazepine | 0615-4515 |
| Sandoz Inc | carbamazepine | 0781-8016 |
| Upsher-Smith Laboratories LLC | carbamazepine | 0832-6022 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
carbamazepine drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | carbamazepine | 46708-731 |
| Alembic Pharmaceuticals Inc | carbamazepine | 62332-731 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 28
carbamazepine drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Coupler LLC | carbamazepine | 67046-1455 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
carbamazepine drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | carbamazepine | 0904-6885 |
| Nostrum Laboratories Inc | carbamazepine | 29033-019 |
| Coupler LLC | carbamazepine | 67046-1455 |
| Coupler LLC | carbamazepine | 67046-1558 |
| Coupler LLC | carbamazepine | 67046-1559 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTRATES
carbamazepine drug variants containing DEXTRATES
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | carbamazepine | 0781-8016 |
| Upsher-Smith Laboratories LLC | carbamazepine | 0832-6022 |
| Torrent Pharmaceuticals Limited | carbamazepine | 13668-284 |
| Trigen Laboratories LLC | carbamazepine | 13811-523 |
| Rising Pharma Holdings Inc | carbamazepine | 16571-680 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing DEXTRATES
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIETHYL PHTHALATE
carbamazepine drug variants containing DIETHYL PHTHALATE
carbamazepine drug variants not containing DIETHYL PHTHALATE
Excipient focus: ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
carbamazepine drug variants containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | carbamazepine | 59746-789 |
| UMEDICA LABORATORIES PRIVATE LIMITED | carbamazepine | 60290-058 |
| Bryant Ranch Prepack | carbamazepine | 63629-5914 |
| REMEDYREPACK INC | carbamazepine | 70518-3699 |
| REMEDYREPACK INC | carbamazepine | 70518-3773 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
carbamazepine drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| NCS HealthCare of KY LLC dba Vangard Labs | carbamazepine | 0615-3505 |
| Major Pharmaceuticals | carbamazepine | 0904-6885 |
| STAT RX USA LLC | carbamazepine | 16590-475 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing ETHYLCELLULOSE
Excipient focus: ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A
carbamazepine drug variants containing ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | carbamazepine | 59746-789 |
| UMEDICA LABORATORIES PRIVATE LIMITED | carbamazepine | 60290-058 |
| Bryant Ranch Prepack | carbamazepine | 63629-5914 |
| REMEDYREPACK INC | carbamazepine | 70518-3699 |
| REMEDYREPACK INC | carbamazepine | 70518-3773 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSES
carbamazepine drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | carbamazepine | 54868-0147 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
carbamazepine drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | carbamazepine | 0904-6885 |
| Nostrum Laboratories Inc | carbamazepine | 29033-019 |
| Taro Pharmaceuticals USA Inc | carbamazepine | 51672-4151 |
| Coupler LLC | carbamazepine | 67046-1455 |
| Coupler LLC | carbamazepine | 67046-1558 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
carbamazepine drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | carbamazepine | 0904-6885 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| Nostrum Laboratories Inc | carbamazepine | 29033-019 |
| Validus Pharmaceuticals LLC | carbamazepine | 30698-419 |
| Takeda Pharmaceuticals America Inc | carbamazepine | 54092-171 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
carbamazepine drug variants containing FD&C RED NO. 40
carbamazepine drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C RED NO. 40 ALUMINUM LAKE
carbamazepine drug variants containing FD&C RED NO. 40 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | carbamazepine | 0904-3854 |
| Cardinal Health 107 LLC | carbamazepine | 55154-1396 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing FD&C RED NO. 40 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
carbamazepine drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| Major Pharmaceuticals | carbamazepine | 0904-7116 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0029 |
| Atlantic Biologicals Corps | carbamazepine | 17856-4047 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
carbamazepine drug variants containing FERRIC OXIDE RED
carbamazepine drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
carbamazepine drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | carbamazepine | 0904-6885 |
| Torrent Pharmaceuticals Limited | carbamazepine | 13668-284 |
| Trigen Laboratories LLC | carbamazepine | 13811-523 |
| Rising Pharma Holdings Inc | carbamazepine | 16571-680 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
carbamazepine drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | carbamazepine | 0832-6022 |
| Torrent Pharmaceuticals Limited | carbamazepine | 13668-284 |
| Trigen Laboratories LLC | carbamazepine | 13811-523 |
| Rising Pharma Holdings Inc | carbamazepine | 16571-680 |
| Northstar Rx LLC | carbamazepine | 16714-063 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
carbamazepine drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | carbamazepine | 0904-6885 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| Nostrum Laboratories Inc | carbamazepine | 29033-019 |
| Validus Pharmaceuticals LLC | carbamazepine | 30698-419 |
| Taro Pharmaceuticals USA Inc | carbamazepine | 51672-4151 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
carbamazepine drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| NCS HealthCare of KY LLC dba Vangard Labs | carbamazepine | 0615-3505 |
| STAT RX USA LLC | carbamazepine | 16590-475 |
| Mylan Institutional Inc | carbamazepine | 51079-385 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing GLYCERIN
Excipient focus: HETASTARCH
carbamazepine drug variants containing HETASTARCH
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | carbamazepine | 13668-284 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing HETASTARCH
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
carbamazepine drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Lundbeck Pharmaceuticals LLC | carbamazepine | 67386-621 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
carbamazepine drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | carbamazepine | 0832-6022 |
| Trigen Laboratories LLC | carbamazepine | 13811-523 |
| Rising Pharma Holdings Inc | carbamazepine | 16571-680 |
| Northstar Rx LLC | carbamazepine | 16714-063 |
| Ajanta Pharma USA Inc | carbamazepine | 27241-231 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
carbamazepine drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| Upsher-Smith Laboratories LLC | carbamazepine | 0832-6022 |
| Major Pharmaceuticals | carbamazepine | 0904-3854 |
| Rising Pharma Holdings Inc | carbamazepine | 16571-680 |
| Ajanta Pharma USA Inc | carbamazepine | 27241-231 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
carbamazepine drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | carbamazepine | 59746-789 |
| UMEDICA LABORATORIES PRIVATE LIMITED | carbamazepine | 60290-058 |
| Bryant Ranch Prepack | carbamazepine | 63629-5914 |
| REMEDYREPACK INC | carbamazepine | 70518-3699 |
| REMEDYREPACK INC | carbamazepine | 70518-3773 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
carbamazepine drug variants containing HYPROMELLOSE 2910
carbamazepine drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
carbamazepine drug variants containing HYPROMELLOSES
carbamazepine drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
carbamazepine drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | carbamazepine | 16714-063 |
| Ajanta Pharma USA Inc | carbamazepine | 27241-231 |
| Zydus Pharmaceuticals (USA) Inc | carbamazepine | 68382-555 |
| REMEDYREPACK INC | carbamazepine | 70518-3929 |
| Zydus Lifesciences Limited | carbamazepine | 70771-1468 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
carbamazepine drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| NCS HealthCare of KY LLC dba Vangard Labs | carbamazepine | 0615-3505 |
| STAT RX USA LLC | carbamazepine | 16590-475 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
carbamazepine drug variants containing MAGNESIUM STEARATE
carbamazepine drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| Major Pharmaceuticals | carbamazepine | 0904-6885 |
| Major Pharmaceuticals | carbamazepine | 0904-7116 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0029 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
carbamazepine drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | carbamazepine | 0781-8016 |
| Upsher-Smith Laboratories LLC | carbamazepine | 0832-6022 |
| Torrent Pharmaceuticals Limited | carbamazepine | 13668-284 |
| Trigen Laboratories LLC | carbamazepine | 13811-523 |
| Rising Pharma Holdings Inc | carbamazepine | 16571-680 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
carbamazepine drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Nostrum Laboratories Inc | carbamazepine | 29033-019 |
| Coupler LLC | carbamazepine | 67046-1455 |
| Coupler LLC | carbamazepine | 67046-1558 |
| Coupler LLC | carbamazepine | 67046-1559 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
carbamazepine drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
carbamazepine drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | carbamazepine | 54092-171 |
| Prasco Laboratories | carbamazepine | 66993-407 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
carbamazepine drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| VGYAAN Pharmaceuticals LLC | carbamazepine | 72664-218 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
carbamazepine drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Unichem Pharmaceuticals (USA) Inc | carbamazepine | 29300-382 |
| VGYAAN Pharmaceuticals LLC | carbamazepine | 72664-218 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: OLEIC ACID
carbamazepine drug variants containing OLEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Nostrum Laboratories Inc | carbamazepine | 29033-019 |
| Coupler LLC | carbamazepine | 67046-1455 |
| Coupler LLC | carbamazepine | 67046-1558 |
| Coupler LLC | carbamazepine | 67046-1559 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing OLEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
carbamazepine drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | carbamazepine | 0904-7116 |
| Atlantic Biologicals Corps | carbamazepine | 17856-4047 |
| ANI Pharmaceuticals Inc | carbamazepine | 70954-240 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
carbamazepine drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | carbamazepine | 0781-8016 |
| Upsher-Smith Laboratories LLC | carbamazepine | 0832-6022 |
| Rising Pharma Holdings Inc | carbamazepine | 16571-680 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| Ajanta Pharma USA Inc | carbamazepine | 27241-231 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
carbamazepine drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Trigen Laboratories LLC | carbamazepine | 13811-523 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
carbamazepine drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | carbamazepine | 59746-789 |
| UMEDICA LABORATORIES PRIVATE LIMITED | carbamazepine | 60290-058 |
| Bryant Ranch Prepack | carbamazepine | 63629-5914 |
| REMEDYREPACK INC | carbamazepine | 70518-3699 |
| REMEDYREPACK INC | carbamazepine | 70518-3773 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
carbamazepine drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | carbamazepine | 59746-789 |
| UMEDICA LABORATORIES PRIVATE LIMITED | carbamazepine | 60290-058 |
| Bryant Ranch Prepack | carbamazepine | 63629-5914 |
| REMEDYREPACK INC | carbamazepine | 70518-3699 |
| REMEDYREPACK INC | carbamazepine | 70518-3773 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
carbamazepine drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | carbamazepine | 13668-284 |
| Northstar Rx LLC | carbamazepine | 16714-063 |
| AustarPharma LLC | carbamazepine | 35561-355 |
| Alembic Pharmaceuticals Limited | carbamazepine | 46708-420 |
| Ingenus Pharmaceuticals LLC | carbamazepine | 50742-257 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
carbamazepine drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Avera McKennan Hospital | carbamazepine | 69189-0410 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM SORBATE
carbamazepine drug variants containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| Major Pharmaceuticals | carbamazepine | 0904-7116 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0029 |
| Atlantic Biologicals Corps | carbamazepine | 17856-4047 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POTASSIUM SORBATE
Excipient focus: POVIDONE
carbamazepine drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| Validus Pharmaceuticals LLC | carbamazepine | 30698-419 |
| Takeda Pharmaceuticals America Inc | carbamazepine | 54092-171 |
| Physicians Total Care Inc | carbamazepine | 54868-5432 |
| Prasco Laboratories | carbamazepine | 66993-407 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: POWDERED CELLULOSE
carbamazepine drug variants containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| AustarPharma LLC | carbamazepine | 35561-355 |
| Chartwell RX LLC | carbamazepine er | 62135-927 |
| American Health Packaging | carbamazepine | 68084-561 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
carbamazepine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| Upsher-Smith Laboratories LLC | carbamazepine | 0832-6022 |
| Major Pharmaceuticals | carbamazepine | 0904-7116 |
| Torrent Pharmaceuticals Limited | carbamazepine | 13668-284 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
carbamazepine drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | carbamazepine | 0832-6022 |
| Major Pharmaceuticals | carbamazepine | 0904-6885 |
| Torrent Pharmaceuticals Limited | carbamazepine | 13668-284 |
| Rising Pharma Holdings Inc | carbamazepine | 16571-680 |
| Northstar Rx LLC | carbamazepine | 16714-063 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICA
carbamazepine drug variants containing SILICA
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | carbamazepine | 50090-5740 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SILICA
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
carbamazepine drug variants containing SILICON DIOXIDE
carbamazepine drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CITRATE
carbamazepine drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | carbamazepine | 62135-802 |
| Precision Dose Inc | carbamazepine | 68094-007 |
| Precision Dose Inc | carbamazepine | 68094-008 |
| Chartwell Governmental & Specialty RX LLC | carbamazepine | 68999-802 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
carbamazepine drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lundbeck Pharmaceuticals LLC | carbamazepine | 67386-621 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURETH SULFATE
carbamazepine drug variants containing SODIUM LAURETH SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| AustarPharma LLC | carbamazepine | 35561-355 |
| Chartwell RX LLC | carbamazepine er | 62135-927 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SODIUM LAURETH SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
carbamazepine drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | carbamazepine | 0781-8016 |
| Upsher-Smith Laboratories LLC | carbamazepine | 0832-6022 |
| Torrent Pharmaceuticals Limited | carbamazepine | 13668-284 |
| Trigen Laboratories LLC | carbamazepine | 13811-523 |
| Rising Pharma Holdings Inc | carbamazepine | 16571-680 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
carbamazepine drug variants containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Lundbeck Pharmaceuticals LLC | carbamazepine | 67386-621 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
carbamazepine drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
carbamazepine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SORBITOL
carbamazepine drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| NCS HealthCare of KY LLC dba Vangard Labs | carbamazepine | 0615-8125 |
| Major Pharmaceuticals | carbamazepine | 0904-7116 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SORBITOL
Excipient focus: SORBITOL SOLUTION
carbamazepine drug variants containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | carbamazepine | 62135-802 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
carbamazepine drug variants containing STARCH, CORN
carbamazepine drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
carbamazepine drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | carbamazepine | 13668-268 |
| NuCare Pharmaceuticals Inc | carbamazepine | 66267-278 |
| Contract Pharmacy Services-PA | carbamazepine | 67046-096 |
| REMEDYREPACK INC | carbamazepine | 70518-0902 |
| REMEDYREPACK INC | carbamazepine | 70518-2456 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
carbamazepine drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | carbamazepine | 0904-6885 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
carbamazepine drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| Major Pharmaceuticals | carbamazepine | 0904-3854 |
| Major Pharmaceuticals | carbamazepine | 0904-7116 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0029 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SUCROSE
Excipient focus: SULFOBUTYLETHER .BETA.-CYCLODEXTRIN
carbamazepine drug variants containing SULFOBUTYLETHER .BETA.-CYCLODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Lundbeck Pharmaceuticals LLC | carbamazepine | 67386-621 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing SULFOBUTYLETHER .BETA.-CYCLODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
carbamazepine drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Trigen Laboratories LLC | carbamazepine | 13811-523 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| Validus Pharmaceuticals LLC | carbamazepine | 30698-419 |
| AustarPharma LLC | carbamazepine | 35561-355 |
| Alembic Pharmaceuticals Limited | carbamazepine | 46708-731 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
carbamazepine drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | carbamazepine | 0832-6022 |
| Major Pharmaceuticals | carbamazepine | 0904-6885 |
| Trigen Laboratories LLC | carbamazepine | 13811-523 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| Nostrum Laboratories Inc | carbamazepine | 29033-019 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
carbamazepine drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0407 |
| Validus Pharmaceuticals LLC | carbamazepine | 30698-419 |
| Taro Pharmaceuticals USA Inc | carbamazepine | 51672-4151 |
| Takeda Pharmaceuticals America Inc | carbamazepine | 54092-171 |
| Physicians Total Care Inc | carbamazepine | 54868-5432 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
carbamazepine drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0029 |
| Morton Grove Pharmaceuticals Inc | carbamazepine | 60432-129 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: VANILLIN
carbamazepine drug variants containing VANILLIN
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0029 |
| Morton Grove Pharmaceuticals Inc | carbamazepine | 60432-129 |
| Chartwell RX LLC | carbamazepine | 62135-802 |
| Precision Dose Inc | carbamazepine | 68094-007 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing VANILLIN
Excipient focus: WATER
carbamazepine drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| Major Pharmaceuticals | carbamazepine | 0904-7116 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0029 |
| Atlantic Biologicals Corps | carbamazepine | 17856-4047 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing WATER
Excipient focus: XANTHAN GUM
carbamazepine drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| Major Pharmaceuticals | carbamazepine | 0904-7116 |
| ATLANTIC BIOLOGICALS CORP | carbamazepine | 17856-0029 |
| Atlantic Biologicals Corps | carbamazepine | 17856-4047 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing XANTHAN GUM
Excipient focus: ZEA MAYS
carbamazepine drug variants containing ZEA MAYS
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | carbamazepine | 50090-5740 |
| >Company | >Ingredient | >NDC |
carbamazepine drug variants not containing ZEA MAYS
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbamazepine | 0078-0508 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0090 |
| Teva Pharmaceuticals USA Inc | carbamazepine | 0093-0109 |
| PAI Holdings LLC | carbamazepine | 0121-0862 |
| PAI Holdings LLC | carbamazepine | 0121-0947 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
